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ell signaling does not occur randomly over the cell
surface, but is integrated within cholesterol-enriched
membrane domains, termed rafts. By targeting SHP-2
to raft domains or to a non-raft plasma membrane fraction,
we studied the functional role of rafts in signaling. Serum-
depleted, nonattached cells expressing the raft SHP-2 form,
but not non-raft SHP-2, display signaling events resembling
 
those observed after fibronectin attachment, such as 
 

 
1
 
integrin clustering, 
 
397
 
Y-FAK phosphorylation, and ERK
activation, and also increases Rho-GTP levels. Expression of
C
 
the dominant negative N19Rho abrogates raft-SHP-2–induced
signaling, suggesting that Rho activation is a downstream
event in SHP-2 signaling. Expression of a catalytic inactive
SHP-2 mutant abrogates the adhesion-induced feedback
inhibition of Rho activity, suggesting that SHP-2 contributes
to adhesion-induced suppression of Rho activity. Because
raft recruitment of SHP-2 occurs physiologically after cell
attachment, these results provide a mechanism by which
SHP-2 may influence cell adhesion and migration by
spatially regulating Rho activity.
 
Introduction
 
Cell functions such as motility require recognition of posi-
tional cues coupled to temporal and spatial reorganization of
the actin cytoskeleton (Mañes et al., 2001). This is largely
affected by integrins, a family of 
 

 
/
 

 
 heterodimeric adhesion
receptors that link the cytoskeleton to the extracellular
matrix (ECM).* Although these adhesion receptors lack
intrinsic signaling capacity, integrins can signal through the
cell membrane by assembling ECM proteins, integrins, intra-
cellular molecules, and the cytoskeleton into supramolecular
complexes known as focal adhesions. Integrins may be con-
sidered both acceptors and donors of signaling (Giancotti
and Ruoslahti, 1999), as ECM binding triggers signals that
are transmitted into the cell (outside-in signaling), but cell
molecules also regulate the extracellular activity of integrins
(inside-out signaling).
Integrin-mediated cell adhesion creates a hierarchy of sig-
naling events that can be separated kinetically and topologi-
cally. One of the earliest detectable biochemical responses to
fibronectin (Fn)-induced integrin engagement is the rapid
tyrosine phosphorylation of various intracellular proteins.
This is due to activation of two nonreceptor protein tyrosine
kinases, the membrane-associated Src family kinases (SFK),
and the cytoplasmic p125 focal adhesion kinase (FAK)
(Schlaepfer et al., 1999). In accordance with the current hy-
pothesis, FAK is first phosphorylated at 
 
397
 
Y; this serves as a
high-affinity site for SFK, which further phosphorylates
FAK on 
 
407
 
Y, 
 
576
 
Y, 
 
577
 
Y, 
 
861
 
Y, and 
 
925
 
Y (Schlaepfer et al.,
1999). Thus, both FAK and SFK initiate an integrin-induced
phosphorylation cascade, although it is unclear how these
events regulate the actin cytoskeleton reorganization neces-
sary for focal adhesion assembly. Evidence places tyrosine
kinases both up- (Mayer et al., 1999; Arthur et al., 2000)
and downstream (Barry et al., 1997; Clark et al., 1998) of
Rho GTPases. There is also considerable controversy as to
whether activation of other downstream signaling pathways,
such as the mitogen-activated protein kinase (MAPK)/extra-
cellular signal-regulated kinase (ERK) pathway, requires ac-
tivity of FAK, SFK, or both (Schlaepfer et al., 1999).
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*Abbreviations used in this paper: CD, methyl-
 

 
-cyclodextrin; Cho,
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
 
-subunit; DRM, detergent-resistant
membrane; ECM, extracellular matrix; ERK, extracellular signal-regulated
kinase; FAK, focal adhesion kinase; Fn, fibronectin; FRNK, FAK-related
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This scenario is further complicated, as both receptor and
nonreceptor protein tyrosine phosphatases (PTPs) influence
the earliest phases of focal adhesion assembly. The SH2-con-
taining PTP SHP-2 is described as a positive effector in inte-
grin function. To act, SHP-2 must be recruited to the mem-
brane by binding to phosphorylated docking proteins such
as SHPS-1/SIRP-
 

 
1 (Tsuda et al., 1998), indicating that
tyrosine phosphorylation is an upstream event in SHP-2 reg-
ulation of integrin signaling. Cells derived from SHP-2 loss-
of-function mutant embryos or expressing an SHP-2 domi-
nant negative mutant show decreased integrin-induced
MAPK activation, spreading, haptotactic, and chemotactic
responses (Tsuda et al., 1998; Yu et al., 1998; Mañes et al.,
1999b; Oh et al., 1999). Nonetheless, it has been reported
that expression of a dominant SHP-2 mutant increases cell
adhesion and spreading on different ECM components (In-
agaki et al., 2000a).
There is much confusion as to how SHP-2 regulates inte-
grin function. SHP-2 may operate in integrin signaling by
regulating FAK phosphorylation. Cells deficient in SHP-2
activity show FAK hyperphosphorylation (Yu et al., 1998;
Mañes et al., 1999b), as well as increased numbers of actin
stress fibers and focal contacts (Yu et al., 1998; Inagaki et al.,
2000a; Saxton et al., 2000), as reported for FAK-deficient
cells (Ilic et al., 1995). Accordingly, embryos bearing an
SHP-2 loss-of-function mutant show gastrulation defects
similar to those of FAK knockout embryos (Ilic et al., 1995;
Saxton et al., 1997). SHP-2 may also regulate FAK function
indirectly by inducing SFK activation (Oh et al., 1999). In
this pathway, integrins induce weak SFK activation that re-
sults in SHP-2 membrane recruitment; once there, SHP-2
further activates SFK by dephosphorylation. It is also un-
clear how SHP-2 rearranges the actin cytoskeleton. Some re-
ports suggest that SHP-2 inhibits RhoA activity (Kodama et
al., 2000; Schoenwaelder et al., 2000), whereas others pro-
pose that SHP-2 regulates Rho positively (Inagaki et al.,
2000b; O’Reilly et al., 2000).
The mechanisms by which integrin engagement coordi-
nates the activation of these signaling pathways is presently
unclear, although both ligand binding and lateral aggrega-
tion of integrins are essential steps. The conventional picture
of membrane proteins diffusing freely in the bilayer has
evolved in recent years, as a growing body of evidence sug-
gests that there is a selective confinement of lipids and pro-
teins to discrete detergent-insoluble glycosphingolipid-,
sphingomyelin-, and cholesterol (Cho)-enriched domains,
termed rafts (Brown and London, 2000). Although initially
proposed as platforms for the selective sorting of membrane
proteins, it is recognized that lipid rafts may also impose
short- and long-range lateral organization of plasma mem-
brane constituents. This is of utmost relevance for integra-
tion of complex signaling processes such as cell migration, as
rafts may favor protein interactions in specific cell locations
(Mañes et al., 1999a; Gómez-Moutón et al., 2001). Accord-
ingly, a number of signaling molecules, including integrins
and integrin-associated proteins, are preferentially activated
in rafts (for review see Brown and London, 2000; Pande,
2000). The role of caveolae in integrin function seems to be
the opposite of that reported for rafts. Integrins are not gen-
erally considered to locate in caveolae (Lisanti et al., 1994;
Mineo et al., 1996), and the interaction between caveolin-1
and 
 

 
1 integrins is reported to occur in a Triton X-100–sol-
uble plasma membrane fraction (Wary et al., 1998). Other
authors suggest a scenario in which 
 

 
1 integrin, caveolin,
and SFK complexes exist as signaling units in caveolae, but
segregate from them in response to ligand-induced cluster-
ing and cytoskeletal reorganization (Wei et al., 1999).
Here we report that cell attachment to Fn induces recruit-
ment of 
 

 
1 integrin, SFK, FAK, and SHP-2 to raft domains
in wild-type cells, suggesting that integration of these signal-
Figure 1. SHP-2 function is needed for cell adhesion and spreading 
on Fn. (A) Serum-starved mock- (), cytSHP-2– (), or cytSHP-2C/S–
transfected () 293T cells were added to Fn-coated plates. Images 
were recorded by phase-contrast microscopy (200) at distinct 
times after replating. Representative fields are shown (n  5). (B) 
Quantification of random fields in five experiments in (A). (C) Mock- 
(), cytSHP-2– (), cytSHP-2C/S– (), FRNK- (), or cytSHP-2C/
SFRNK–transfected () cells were replated on dishes coated with 
several Fn concentrations; adhered cells were estimated after 15 
min incubation (n  4; **, P  0.01, two-tailed t test).
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ing pathways occurs in rafts. Specific SHP-2 targeting to
rafts eludes the tyrosine kinase signaling step required for
SHP-2 activation after cell attachment, providing a unique
model to study SHP-2 function.
 
Results
 
SHP-2 activity is required for integrin function
 
We analyzed the role of SHP-2 downstream of 
 

 
1 integrins
in human embryonic kidney 293T cells by expressing a cata-
lytic inactive dominant mutant of this enzyme (cytSHP-2C/
S). SHP-2C/S overexpression drastically delays 293T cell
spreading on Fn compared to mock-transfected cells or cells
expressing the wild-type SHP-2 (cytSHP-2) form (Fig. 1, A
and B). Even at long adhesion times (60 min), SHP-2C/S
cells show defects in polarized extension, with a rounded
morphology (Fig. 1 A). Cells expressing the mutant also
showed decreased adhesion to this ECM substrate (Fig. 1
C). To study the role of SHP-2 in integrin function, we co-
expressed SHP-2C/S with the FAK C-terminal domain
(FAK-related nonkinase [FRNK]). FRNK overexpression
interferes with FAK function in a dominant inhibitory man-
ner, reducing FAK tyrosine phosphorylation and focal adhe-
sion assembly (Schlaepfer et al., 1999). FRNK expression
reduces cell adhesion to Fn; FRNK and SHP-2C/S coex-
pression further decreases cell adhesion to this substrate (Fig.
1 C). These results show that SHP-2 activity is required for
integrin function.
 
SHP-2 is engaged in an Fn-induced signaling complex 
in membrane rafts
 
Next, we addressed SHP-2 partitioning in rafts after inte-
grin engagement. Serum-starved cells were replated on Fn-
coated dishes for different times; after elimination of nonad-
hered cells, the Triton X-100–insoluble membrane fraction
was isolated in flotation gradients. Raft-associated proteins
float in density gradients as detergent-resistant membranes
(DRMs), whereas the insoluble complexes formed by associ-
ation with the cytoskeleton, as well as cytosolic and non-raft
membrane proteins, copurify at the gradient bottom. Fn at-
tachment triggers early recruitment of SHP-2, as well as of
 

 
1
 
 integrin and FAK, to the DRM fraction (Fig. 2 A). SFK
proteins, visualized with a pan-SRC antibody, are constitu-
tively associated to DRM. Copurification of caveolin in
DRM and the full solubilization of non-raft proteins such as
the transferrin receptor (TfR) confirm the quality of the
preparation.
Flotation gradients probably underestimate the amount of
raft-associated FAK and 
 

 
1, as a fraction of activated FAK
and 
 

 
1 associate with cytoskeleton. Thus, we validated the re-
cruitment of these proteins to rafts in situ by confocal micros-
copy. Cells were costained with anti–phospho-
 
397
 
Y-FAK or
anti-
 

 
1 antibodies and with the cholera toxin 
 

 
-subunit
(CTx), which binds specifically to the raft-ganglioside GM1.
Cells attached on poly-
 
L
 
-lysine or maintained in suspension
do not stain with anti–phospho–
 
397
 
Y-FAK antibody (Fig. 2
B). Plating these cells on Fn resulted in increased 
 
397
 
Y-FAK
staining, which colocalizes with CTx (Fig. 2, C and D), indi-
cating that attachment to Fn induces 
 
397
 
Y-FAK and raft clus-
tering at the cell membrane (Fig. 2, C and D). However, 
 

 
1
integrin appears constitutively associated to rafts, as it colocal-
izes with CTx in both nonadhered (Fig. 2 E) and adhered cells
(Fig. 2, F and G). This result is in contrast with the modest
colocalization between 
 

 
1 and the caveolae marker caveolin-1
reported by others (Wei et al., 1999), again indicating differ-
ences between rafts and caveolae in integrin function. None-
theless, 
 

 
1 colocalization with CTx contrasts with the non-
raft partitioning of 
 

 
1 integrin in nonattached cell flotation
gradients. The difference between these techniques may re-
flect weak association of 
 

 
1 with lipid rafts in nonadhered
cells, which is stabilized after cell attachment.
Identification of integrins and integrin-associated proteins
in the DRM fraction indicates that early integrin signaling is
Figure 2. Early integrin signaling is engaged in rafts. (A) Serum-
starved 293T cells maintained in suspension or replated on
Fn-coated plates were Triton X-100 extracted and fractionated in 
Optiprep gradients. Fractions were collected from top to bottom of 
the gradient and analyzed by Western blot with the indicated anti-
bodies. Only the first (I, DRM-enriched) and last fractions (S, Triton 
X-100–soluble material) are shown. Data are representative of four 
independent experiments. (B–G) Nonattached (B and E) or Fn-adhered 
cells for 5 (C and F) or 30 min (D and G) were costained with 
FITC-CTx (green) and anti–397Y-FAK (B–D) or anti-1 (E–G), 
followed by a Cy3-labeled second antibody (red), and analyzed by 
confocal microscopy. Single-color images are available online at 
http://www.jcb.org/cgi/content/full/jcb.200109031/DC1. Bar, 5 m.
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engaged in rafts. In addition, depletion of membrane Cho
with the drug methyl-
 

 
-cyclodextrin (CD) delays 293T cell
spreading on Fn, which is restored by adding free Cho to
CD-treated cells (Fig. 3); this suggests that cell spreading is
dependent on levels of membrane Cho, a lipid particularly
abundant in rafts.
 
Raft partitioning of SHP-2 accelerates 
integrin signaling
 
If integrin signaling takes places in rafts, targeting these inter-
mediates to rafts would provide a kinetic advantage to integrin
signaling by increasing the interaction efficiency of down-
stream targets. Double palmitoylation signals of p56LCK are
a major determinant in targeting this protein to rafts (Kabou-
ridis et al., 1997). We constructed a SHP-2 chimera by add-
ing the 12 amino acids corresponding to the Lck unique do-
main, which bears the double 
 
S
 
-acylation signal, to the SHP-2
N terminus. A membrane-bound SHP-2 chimera with the
human c-SRC myristoylation tag was also used (Zhao and
Zhao, 1999). Confocal analysis showed that whereas LCK-
SHP2 and SRC-SHP2 are targeted to the plasma membrane,
only LCK-SHP2 shows extensive colocalization with the raft
marker GM1 (Fig. 4 A). In agreement, flotation gradients
showed that only LCK-SHP2 partitions constitutively in
DRM, whereas SRC-SHP2 recruitment to DRM requires in-
tegrin engagement (Fig. 4 B).
We analyzed the in vitro PTP activity of the SHP-2 chi-
meras. Lysates from serum-starved 293T cells expressing the
distinct SHP-2 constructs were immunoprecipitated using
an anti-6His tag antibody, and PTP activity in the pellet was
assayed using pNPP as substrate. Because the C-terminal
6His tag is distant from the SH2 domains, the immunopre-
cipitation step should not result in SHP-2 activation. We
Figure 3. Cho depletion inhibits cell spreading. Serum-starved 
cells were untreated (	, ), CD-treated (), or replenished with Cho 
after CD treatment (CD  Cho, ). Phase-contrast images were 
recorded at different times to evaluate cell spreading by direct 
counting. Representative fields and quantification are shown (n  5).
Figure 4. Membrane targeting of SHP-2. (A) SHP-2 and GM1 
distribution was analyzed by confocal microscopy in nonattached 
cytSHP-2, SRC-SHP2, or LCK-SHP2 cells by costaining with FITC-CTx 
(green) and anti–SHP-2 antibody (red); yellow indicates SHP-2 and 
GM1 colocalization. Single-color images are available online at 
http://www.jcb.org/cgi/content/full/jcb.200109031/DC1. Bar, 5 m. 
(B) cytSHP-2, SRC-SHP2, or LCK-SHP2 cells maintained in suspension 
or replated on Fn-coated dishes for 5 min were fractionated to 
analyze DRM partitioning of SHP-2 (DRM [I] and soluble [S] fractions). 
The lower band corresponds to endogenous SHP-2. Representative 
data are shown (n  4). (C) Lysates of mock, cytSHP-2, SRC-SHP2, 
LCK-SHP2, SH2-truncated 
SHP-2, or 
SHP-2C/S cells were 
immunoprecipitated with anti-6His antibody and PTP activity 
determined in pellets using pNPP as substrate. Values are expressed 
as picomoles of phosphate released per minute. Background level is 
indicated with a dashed line. As a control of protein quantity, part of 
the immunoprecipitate was analyzed in Western blot using anti–SHP-2 
antibody. (D) Lysates from serum-starved 293T cells expressing the 
catalytic active or inactive SHP-2 chimeras indicated were immuno-
precipitated with a polyclonal anti–SHP-2 antibody and the pellets 
used to analyze PTP activity as in (C). Western blot analysis of 
pellets with anti–SHP-2 antibody is shown.
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observed near-background PTP activity levels in anti-6His
pellets from cytSHP-2–, SRC-SHP2–, and LCK-SHP2–
expressing cells (Fig. 4 C). PTP activity was prominent in
anti-6His pellets of cells expressing an SH2-truncated SHP-2
mutant (
 


 
SHP-2) described to be constitutively active (Zhao
and Zhao, 1999). PTP activity was also measured in immu-
noprecipitates using anti–SHP-2 antibody. Anti–SHP-2 im-
munoprecipitates from mock-, cytSHP-2–, SRC-SHP2–, or
LCK-SHP2–expressing cells showed significant PTP activity,
which was not detected in anti–SHP-2 pellets from catalyti-
cally inactive C/S mutant cells (Fig. 4 D). The results suggest
partial, specific SHP-2 PTP activation after anti–SHP-2 anti-
body binding. Comparable cytSHP-2, SRC-SHP2, and
LCK-SHP2 protein levels showed similar PTP activity, thus
suggesting that addition of SRC or LCK tags to the N termi-
nus of SHP-2 does not promote enzyme activation.
As rafts are the sites at which integrins are clustered and
FAK is activated (Fig. 2, B–G), one would predict that
SHP-2 targeting to rafts would enhance its presence in focal
adhesions. We found that a fraction LCK-SHP2 colocalizes
with paxillin in well-spread cells, whereas staining of paxillin
and non-raft SRC-SHP2 or cytSHP-2 is completely inde-
pendent (Fig. 5 A). We tested whether SHP-2 partitioning
affects integrin function. Membrane targeting of SHP-2 to a
non-raft location does not enhance integrin function, as
spreading of cells expressing SRC-SHP2 is indistinguishable
from that of cells overexpressing the cytosolic enzyme (cyt-
SHP-2) (Fig. 5 B) or transfected with an empty vector
(unpublished data). Nonetheless, cells expressing the raft-
associated LCK-SHP2 chimera spread more rapidly than
SRC-SHP2 or cytSHP-2 cells on Fn. Thus, raft targeting of
LCK-SHP2 provides a kinetic advantage, concurring with
the idea that integrin signaling is organized in rafts. This is
not the consequence of a docking effect, but requires SHP-2
catalytic activity, as expression of a raft-located catalytically
inactive SHP-2 mutant (LCK-SHP2C/S) delays cell spread-
ing on Fn (Fig. 5 B).
 
Raft targeting of SHP-2 activates ERKs
 
We measured the functional consequences of SHP-2 parti-
tioning on integrin signaling. SHP-2 positively regulates
ERK1/2 downstream of 
 

 
1 integrins; indeed, SHP-2C/S
overexpression inhibits Fn-induced MAPK activation. West-
ern blot with antibodies to the dual-phosphorylated active
ERK1/2 forms shows that there is little or no active ERK1/2
in nonattached mock-, cytSHP-2–, or SRC-SHP2–trans-
fected cells (Fig. 5 C). Cell attachment to Fn promotes tran-
sient ERK1/2 activation that is comparable among the three
cell types (Fig. 5 C), indicating that SHP-2 overexpression
does not affect integrin signaling. However, in LCK-SHP2
cells, ERK1/2 are activated in the absence of Fn stimulation
(Fig. 5 C). Despite this basal activation, Fn-induced ERK
activation in LCK-SHP2 cells reaches levels similar to those
of SRC-SHP2 or cytSHP-2 cells.
SHP-2 may activate ERK by triggering direct or indirect
 
527
 
Y-SFK dephosphorylation after integrin engagement,
resulting in SFK activation (Oh et al., 1999). Nonethe-
less, mock-transfected (unpublished data), cytSHP-2, SRC-
SHP2, or LCK-SHP2 cells show comparable adhesion-
induced SFK phosphorylation in the DRM fraction (Fig. 6 A),
Figure 5. Partition of LCK-SHP2 into rafts enhances SHP-2 signaling. 
(A) Raft-associated LCK-SHP2 is targeted to focal adhesions. 
CytSHP-2–, SRC-SHP2– and LCK-SHP2–expressing cells were 
plated onto Fn for 120 min, then costained with anti-paxillin (red) 
and anti–SHP-2 (green) antibodies. Colocalization (yellow) of 
markers was analyzed by confocal microscopy. Single-color images 
are available online at http://www.jcb.org/cgi/content/full/
jcb.200109031/DC1. Bar, 5 m. (B) Raft-targeted LCK-SHP2 
accelerates cell spreading. cytSHP-2 (), SRC-SHP2 (), LCK-SHP2 
(), or raft-targeted dominant negative LCK-SHP2C/S mutant () 
cells were trypsinized and replated on Fn-coated plates. Phase-
contrast images were recorded at different times to evaluate cell 
spreading. Quantification of four experiments is shown at the right 
(**, P  0.01, two-tailed t test). (C) Raft-targeted LCK-SHP2 triggers 
ERK activation in unstimulated cells. Lysates from serum-starved 
mock, cytSHP-2, SRC-SHP2, LCK-SHP2 or LCK-SHP2C/S cells 
maintained in suspension (sus) or replated on Fn for 5 (att) or 30 min 
(spr) were analyzed by Western blot using anti–phospho-ERK anti-
body. Filters were rehybridized with anti-ERK antibody as a protein 
loading control and with anti–SHP-2 to show SHP-2 expression. 
Results represent four similar experiments.
 o
n
 M
arch 31, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 282 The Journal of Cell Biology 
 
|
 
 
 
Volume 157, Number 2, 2002
 
as well as in vitro SFK activity in nonattached cells (Fig. 6
B), suggesting that the differential partition of SHP-2 does
not modify SFK activity. 
 
527
 
Y-Src phosphorylation is unaf-
 
fected by SHP-2 partition (unpublished data). Pretreatment
of cytSHP-2 or SRC-SHP2 cells with the SFK inhibitor PP2
reduces Fn-induced ERK1/2 activation, although PP2 af-
fects neither basal nor Fn-induced ERK1/2 activation in
LCK-SHP2 cells (Fig. 6, C and D). Thus, specific SHP-2
targeting to rafts, but not to other membrane regions, by-
passes the requirement for SFK activity in Fn-induced ERK
activation. PP2 treatment also significantly reduced Fn-
induced SRC-SHP2 recruitment to rafts, whereas LCK-
SHP2 partitioning in these domains is unaffected (Fig. 6 E).
The results indicate that after integrin engagement, one SFK
function is to recruit SHP-2 to rafts, which may then acti-
vate ERK by an SFK-independent mechanism.
 
Raft-targeted SHP-2 triggers 
 
39
 
7
 
Y-FAK phosphorylation
 
FAK phosphorylation analysis using anti-phosphospecific
antibodies showed a significant 
 
397
 
Y-FAK fraction in nonat-
tached LCK-SHP2 cells, but not in cytSHP-2 or SRC-
SHP2 cells (Fig. 7 A). FAK phosphorylation kinetics in
mock-transfected cells is similar to that in cytSHP-2 or
SRC-SHP2, again indicating that the effect is not due to
SHP-2 overexpression. LCK-SHP2C/S expression abrogates
 
397
 
Y-FAK phosphorylation in nonattached cells (Fig. 7 A),
indicating that the LCK-SHP2 effect requires PTP activity.
Basal FAK phosphorylation in LCK-SHP2 cells is 
 
397
 
Y-spe-
cific, as 
 
861
 
Y-FAK is not observed (Fig. 7 A), consistent with
the conclusion that SHP-2 partitioning does not affect SFK
activity.
FRNK expression inhibits FAK phosphorylation in non-
attached and Fn-adhered LCK-SHP2 cells (Fig. 7 B). Basal
 
397
 
Y-FAK phosphorylation in nonattached LCK-SHP2 cells
is probably the consequence of FAK recruitment to the cell
membrane. FRNK also abolishes accelerated spreading in
LCK-SHP2 cells (unpublished data), and inhibits Fn-induced
ERK activation independently of the SHP-2 form coexpressed.
In addition, FRNK abrogates basal ERK activation in non-
attached LCK-SHP2 cells (Fig. 7 B), suggesting that SHP-2
requires functional FAK for ERK activation.
 
SHP-2 regulates Rho activity
 
Next, we studied the mechanism by which LCK-SHP2
regulates FAK phosphorylation. LCK-SHP2 does not af-
fect 
 

 
1 affinity, as analyzed with the anti-
 

 
1 antibody
HUTS-21, which binds specifically to activated 
 

 
1 inte-
grins (unpublished data). Confocal analysis nonetheless in-
dicates large 
 

 
1 integrin patches on the surface of suspen-
sion LCK-SHP2 cells, compared with diffuse 
 

 
1 staining
in cytSHP2- (unpublished data) or SRC-SHP2 cells (Fig. 8
A). Latrunculin-B disruption of actin cytoskeleton inhibits
 
397
 
Y-FAK phosphorylation of nonattached LCK-SHP2
cells (Fig. 8 B), suggesting that basal LCK-SHP2–induced
signaling is achieved by regulating the actin cytoskeleton.
Cytoskeleton rearrangements are controlled by Rho GTP-
ase family members (Kjoller and Hall, 1999), of which
Rho is particularly prominent, as it influences integrin-
induced ERK activation and FAK phosphorylation (Clark
et al., 1998). To analyze whether Rho function is needed
for LCK-SHP2 signaling in nonattached cells, we coex-
pressed a green fluorescent protein (GFP)-tagged N19Rho
dominant negative mutant with LCK-SHP2. We found
Figure 6. SFK acts upstream, but not downstream, of SHP-2 in 
integrin signaling. (A) Optiprep gradients were prepared from 
suspended or Fn-attached (5 or 30 min) cytSHP-2, SRC-SHP2, or 
LCK-SHP2 cells after TX-100 extraction, and fractions were analyzed 
in Western blot using anti-PY and anti-pan SRC antibodies. Bands 
correspond to tyrosine phosphorylated (top) and total SFK (bottom) in 
the DRM (I) and soluble (S) fractions. Data are representative of three 
experiments. (B) Serum-starved cytSHP-2, SRC-SHP2 or LCK-SHP2 
cells were trypsinized and maintained in suspension. SFK in lysates 
were precipitated with pan-Src antibody and assayed for in vitro 
kinase activity. Results are representative of three experiments. (C) 
Serum-starved cytSHP-2, SRC-SHP2, or LCK-SHP2 cells were untreated 
(	) or treated () with PP2 or PP3 as a control. Equal amounts of 
extracts from cells in suspension (sus) or Fn-adhered for 5 (att) or 30 
min (spr) were blotted with anti–phospho-ERK antibody (top panels). 
Protein loading was controlled using an anti-ERK antibody (bottom 
panels). Data are representative of three independent experiments. 
(D) The phospho-ERK2 band from (C) was measured by densitometry 
and the signal ratio between PP2- and PP3-treated cells calculated; 
cytSHP-2 (), SRC-SHP2 (), and LCK-SHP2 (). (E) SRC-SHP2 or 
LCK-SHP2 cells were treated with PP2 or PP3 as indicated, plated on 
Fn-coated chambers for 5 min, and costained with FITC-CTx (green) 
and SHP-2 (red). Colocalization (yellow) of both markers was analyzed 
by confocal microscopy. Single-color images are available online at 
http://www.jcb.org/cgi/content/full/jcb.200109031/DC1. Bar, 5 m.
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that N19Rho, but not GFP-N17Rac, inhibits 397Y-FAK
phosphorylation in serum-depleted, nonattached LCK-
SHP2 cells (Fig. 9 A).
The N19Rho results suggest that Rho may be down-
stream of SHP-2; thus, we examined whether SHP-2 parti-
tioning affects Rho activity. Serum-depleted, nonattached
LCK-SHP2 cells show higher active Rho levels than those of
non-raft SRC-SHP2 or cytSHP-2 cells (Fig. 9, B and C).
LCK-SHP2C/S expression does not increase, and even re-
duces active Rho levels in nonattached cells (Fig. 9 B). Ex-
pression of neither LCK-SHP2 nor the inhibitor LCK-
SHP2C/S affects Rac activity in nonattached cells (Fig. 9, D
and E); this suggests that SHP-2 is a specific effector for Rho
and that this regulation occurs specifically in rafts. After cell
attachment, active Rho levels follow a biphasic curve, with
an initial decline followed by an increase in Rho-GTP levels.
The initial adhesion-induced Rho inhibition is conserved in-
dependently of the SHP-2 form expressed, but LCK-SHP2
cells show a more rapid, pronounced recovery of Rho activ-
ity than SRC-SHP2 or cytSHP-2 cells (Fig. 9, B and C),
concurring with the hypothesis that SHP-2 regulates Rho
activity in rafts. LCK-SHP2C/S expression abrogates adhe-
sion-induced feedback inhibition of Rho activity, suggesting
that SHP-2 also contributes to the negative regulation of
Rho activity downstream of integrins. Similar results were
obtained in SRC-SHP2C/S and cytSHP-2C/S (unpublished
data). Adhesion-induced Rac activation is unaffected in cells
expressing either the catalytically active or inactive SHP2
chimeras (Fig. 9 D), suggesting that SHP-2 specifically regu-
lates Rho.
Discussion
Recent evidence suggests that clustering (i.e., avidity) of cer-
tain integrins is influenced by their partition into discrete
membrane domains termed rafts (Krauss and Altevogt,
1999; Pande, 2000). Integrin-mediated signaling is inte-
grated in rafts, and formation of integrin signaling com-
plexes with integrin-associated protein/CD47 (Green et al.,
1999) or CD36 (Thorne et al., 2000) is sensitive to Cho de-
Figure 7. Raft targeting of LCK-SHP2 
triggers 397Y-FAK phosphorylation in 
nonadhered cells. (A) Equal amounts of 
lysates from serum-starved cytSHP-2, 
SRC-SHP2, LCK-SHP2, or LCK-SHP2C/S 
cells detached (sus) and replated on Fn 
for 5 (att) or 30 min (spr) were precipitated 
with anti-FAK antibody. Pellets were 
probed with anti–397Y-FAK, –861Y-FAK 
and –FAK antibodies. (B) cytSHP-2, 
SRC-SHP2, or LCK-SHP2 were trans-
fected in 293T cells or in 293T cells 
stably expressing FRNK. Equal amounts 
of lysates from nonattached (sus) and 
Fn-replated for 5 (att) or 30 min (spr) 
were probed with anti–397Y-FAK, -FAK,
–phospho-ERK and -ERK antibodies. 
Anti-HA antibody was used to control 
FRNK expression.
Figure 8. Raft targeting of LCK-SHP2 regulates actin cytoskeleton 
in nonattached cells. (A) Indirect immunofluorescence with anti-1 
antibody of nonattached or Fn-attached SRC-SHP2 or LCK-SHP2 
cells, as indicated. Bar, 5 m. (B) Serum-depleted SRC-SHP2 or 
LCK-SHP2 cells were latrunculin-B-treated, then left in suspension 
(sus) or Fn-replated for 5 (att) or 30 min (spr). FAK was precipitated 
and probed with anti–397Y-FAK and -FAK antibodies (n  3).
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pletion. We report that several proteins that must interact to
function, such as 1 integrin, FAK, SFK, and SHP-2, all re-
distribute to rafts as a consequence of Fn adhesion. Mem-
brane Cho sequestration abrogates Fn-induced cell spread-
ing, implying a functional role for rafts in integrin signaling
complex assembly.
Reinforcing this hypothesis, raft-targeted LCK-SHP2 ac-
celerates integrin-mediated cell spreading compared to non-
raft SRC-SHP2, cytSHP-2, or mock-transfected cells. For
most cell geometry, assuming homogeneous protein distri-
bution, forced membrane expression of a protein should not
significantly increase first-encounter rates with other part-
ners, as diffusion in the membrane is lower than in the cyto-
sol (Kholodenko et al., 2000). This situation shifts when all
elements of a signaling cascade are concentrated within raft
domains of limited area. Thus, targeting LCK-SHP2 to rafts
provides a kinetic advantage (i.e., rapid spreading), as other
integrin signaling elements are recruited to these domains.
These results highlight the role of raft domains as specific
platforms for the coordination of integrin signaling.
SHP-2 signaling induced by specific raft partitioning
SHP-2 activation is a combination of compartmentalization
and conformational changes. Distinct tyrosine-phosphory-
lated docking proteins and tyrosine kinase receptors are im-
plicated in membrane recruitment and activation of SHP-2,
although membrane location alone is insufficient to trigger
its phosphatase activity. SHP-2 contains two SH2 domains,
a catalytic (PTP) domain and a C-terminal tail of unknown
function (van Vactor et al., 1998). In the absence of an ap-
propriate phosphotyrosyl peptide ligand, the N-SH2 do-
main binds to the active site of the PTP domain, inactivat-
ing the enzyme (Hof et al., 1998). N-SH2 binding to a
phosphorylated membrane ligand prevents its union to the
Figure 9. Raft targeting of LCK-SHP2 triggers Rho activation. (A) 397Y-FAK phosphorylation was analyzed in lysates of serum-starved LCK-SHP2, 
LCK-SHP2, and N17Rac or LCK-SHP2 and N19Rho cotransfected cells, in suspension (sus) or Fn-replated for 5 (att) or 30 min (spr). As control, 
blots were hybridized with anti-FAK, -SHP-2, and -Rho antibodies as indicated (n  3). (B) Serum-starved cytSHP-2 (), SRC-SHP2 (), 
LCK-SHP2 (), or LCK-SHP2C/S () cells were extracted, and Rho was assayed (Materials and methods). Data are mean  standard deviations 
(n  3). (C) Blots are shown in one representative experiment from B. (D) Serum-starved cytSHP-2 (), SRC-SHP2 (), LCK-SHP2 (), or 
LCK-SHP2C/S () cells were suspended and replated on Fn for the times indicated. Active Rac was precipitated with the agarose-coupled PAK 
PBD domain. Data are mean  standard deviations (n  3). (E) Blots are shown in one representative experiment from (D). As a loading control, 
Rac was also determined in the corresponding cell lysates.
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PTP domain, thereby activating the enzyme. However, in
unstimulated cells, LCK-SHP2 triggers FAK phosphoryla-
tion, integrin clustering and ERK activation by a mechanism
that requires PTP activity. This signaling is not a conse-
quence of membrane partitioning, as the non-raft SRC-
SHP2 chimera does not signal in unstimulated cells. More-
over, all the chimeras are equally active in vitro, suggesting
that addition of the distinct N-terminal tags does not acti-
vate PTP. Thus, LCK-SHP2 signals in the absence of stimu-
lation provide a unique model for assessment of downstream
consequences of SHP-2 action.
The most striking observation in cells expressing raft-tar-
geted LCK-SHP2 is the specific Rho activation in the ab-
sence of cell stimulation. This basal Rho activation requires
SHP-2 PTP activity, as the catalytic inactive LCK-SHP2C/S
mutant does not show increased Rho activation. LCK-
SHP2C/S does not reduce active Rho levels in non-attached
cells compared to cells expressing cytSHP-2 or the non-raft
SRC-SHP2 chimera, suggesting that SHP-2 PTP activity is
important in activating a regulatory component upstream of
Rho. The substrates dephosphorylated by SHP-2 to control
Rho activity are currently under study. Both guanine-nucle-
otide exchange factors (GEFs) and GTPase-activating pro-
teins (GAPs) are regulated by tyrosine phosphorylation
(Kjoller and Hall, 1999). p190RhoGAP is an interesting
candidate, as increased p190RhoGAP tyrosine phosphoryla-
tion correlates with increased GAP activity (Roof et al.,
1998); moreover, p190RhoGAP inhibition is sufficient to
induce Rho-mediated actin reorganization (Vincent and Set-
tleman, 1999). Thus, SHP-2–induced p190RhoGAP de-
phosphorylation may inhibit GAP activity and increase
Rho-GTP levels. Although control of Rho-GTP by dephos-
phorylating p190RhoGAP fits well with our data in nonat-
tached cells, it does not explain how SHP-2 suppresses Rho
activity after attachment. A role is proposed for Src-induced
p190RhoGAP phosphorylation in the initial adhesion-
dependent Rho inhibition (Arthur et al., 2000); this raises
the possibility that SHP-2 acts directly on different RhoGEFs
or GAPs, or indirectly on a third partner that controls the ac-
tivity of these exchangers (Kodama et al., 2000).
Increased Rho activation in nonattached LCK-SHP2 cells
may be responsible for signaling observed in these cells; i.e.,
FAK phosphorylation and ERK activation. Evidence sup-
porting this conclusion is that N19Rho, but not N17Rac ex-
pression inhibits 397Y-FAK phosphorylation in these cells.
FAK is phosphorylated on multiple sites, some regulated by
autocatalytic activity and others by SFK (Schlaepfer et al.,
1999). LCK-SHP2–induced FAK phosphorylation is spe-
cific for 397Y, whereas 861Y is not affected in nonattached
LCK-SHP2 cells; this suggests that LCK-SHP2–induced
FAK phosphorylation is not mediated by SFK activation.
Several reports indicate that Rho activity may specifically
regulate 397Y-FAK phosphorylation (Barry et al., 1997;
Clark et al., 1998). This effect has been explained by Rho-
induced acto-myosin contraction, which results in adhesion
complex clustering (Chrzanowska-Wodnicka and Burridge,
1996). Interestingly, LCK-SHP2 expression induces 1 in-
tegrin clustering, and LCK-SHP2–induced FAK phosphor-
ylation requires an intact actin cytoskeleton. Taken together,
the results suggest that raft-targeted LCK-SHP2, acting up-
stream of Rho, induces actin cytoskeleton rearrangements
that culminate in clustering of integrin-bound complexes,
resulting in FAK transphosphorylation.
This model may also explain LCK-SHP2–induced ERK
activation in nonattached cells, as FRNK inhibits both 397Y-
FAK phosphorylation and ERK activation in nonattached
LCK-SHP2 cells. The results indicate that SHP-2 requires
397Y-FAK phosphorylation to activate ERKs. SFK activity
appears not to be involved in LCK-SHP2–induced ERK ac-
tivation; indeed, the SFK inhibitor PP2 does not block ERK
activation in nonattached LCK-SHP2 cells. Concurrently,
LCK-SHP2 expression does not affect 527Y-Src phosphoryla-
tion or SFK activity. These data, together with the absence
of 861Y-FAK phosphorylation in nonattached LCK-SHP2
cells, indicate that SFK are not activated by LCK-SHP2. As
discussed below, SFK may operate upstream of SHP-2 in re-
cruiting this phosphatase to raft domains. Analysis of signal-
ing in nonattached LCK-SHP2–expressing cells predicts a
sequence of downstream targets for SHP-2, which may re-
semble that found after integrin engagement.
Effects of SHP-2 partitioning in integrin signaling
Partitioning SHP-2 to different cell locations may help de-
termine its position in the integrin signaling cascade. Two
major differences in integrin-induced events were observed
by targeting LCK-SHP2 to rafts. One is that integrin-
induced ERK activation in LCK-SHP2 cells is not inhibited
by PP2. In the current model, integrin engagement induces
tyrosyl phosphorylation of the SHP substrate 1 (SHPS-1/
SIRP-1) through an SFK-dependent mechanism (Tsuda et
al., 1998; Oh et al., 1999). This recruits and activates SHP-2,
inducing further SFK activation, and leading in turn to
ERK signaling. This model suggests that SHP-2 acts both
up- and downstream of SFK in Fn-induced signaling to
ERK. We observed that, whereas PP2 inhibits the initial
peak of Fn-induced ERK activation in cytSHP-2- or the
non-raft SRC-SHP2–expressing cells, LCK-SHP2 cells are
refractory to PP2-induced ERK inhibition. Because raft tar-
geting of SHP-2 overcomes the PP2 inhibitory effect, we
conclude that once in rafts, SHP-2 may activate ERK by act-
ing on substrates other than SFK. As raft location of SHP-2
is important for ERK activation, SFK activation may be crit-
ical in SHP-2 recruitment to specific membrane locations.
Concurring with this hypothesis, we observed that PP2
treatment inhibits the adhesion-induced recruitment of
non-raft SRC-SHP2 or cytSHP-2 to rafts. These results in-
dicate that SFK acts upstream of SHP-2, inducing phos-
phatase recruitment to raft domains after integrin engage-
ment. SHP-2 location in rafts seems not be involved in SFK
activation, as 527Y-SFK dephosphorylation or 861Y-FAK
phosphorylation are unaffected by expressing the raft-tar-
geted LCK-SHP2 chimera.
The second major difference detected by raft targeting of
SHP-2 is a variation in integrin-induced Rho activation. In-
tegrin engagement to Fn induces transient Rho inhibition,
followed by a phase of Rho activation. Feedback regulation
of Rho is maintained in LCK-SHP2 expressing cells, but
baseline and adhesion-dependent Rho activation are signifi-
cantly enhanced in LCK-SHP2 cells compared to those ex-
pressing SRC-SHP2 or cytSHP-2. This concurs with in-
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creased Rho-GTP levels in nonattached LCK-SHP2 cells,
and reinforces the hypothesis that SHP-2 is a regulator of
Rho. However, expression of the inactive LCK-SHP2C/S
mutant abrogates the initial adhesion-induced Rho inhibi-
tion, suggesting that SHP-2 is also involved in integrin-
induced Rho suppression. It is important to note that
Rho-GTP levels in LCK-SHP2C/S cells do not reach those
observed in cells expressing the active LCK-SHP2 chimera.
One interpretation is that the enhanced active Rho levels in
LCK-SHP2 cells are the result of SHP-2 enzymatic activity
and not the sole consequence of raft partitioning, supporting
a physiological role for SHP-2 in Rho activation. Nonethe-
less, raft targeting of catalytically active or inactive SHP-2
forms does not affect Rac activation downstream of inte-
grins. Together, the results indicate that SHP-2 takes part in
specifically regulating Rho activity.
We integrate our data in a model for SHP-2–induced
ERK activation and cytoskeletal rearrangement downstream
of integrins (Fig. 10). The scheme is partial, as integrins trig-
ger distinct signaling pathways simultaneously. Indeed, we
observed no more than 50% ERK inhibition by blocking in-
dividual signaling pathways (i.e., SHP-2C/S for SHP-2, PP2
for SFK, FRNK for FAK), suggesting that integrins trigger
several independent pathways that converge at ERK activa-
tion (Barberis et al., 2000). We propose that integrin bind-
ing to the ECM substrate promotes SFK activation, which
phosphorylates substrates that recruit SHP-2 to rafts. Acti-
vated SHP-2 in rafts is essential for regulating Rho activity
downstream of integrins, controlling cytoskeletal rearrange-
ments that culminate in integrin clustering and 397Y-FAK
phosphorylation. Both SHP-2C/S and N19Rho expression
inhibit basal and integrin-induced 397Y-FAK phosphoryla-
tion, suggesting that FAK is downstream of these molecules.
Activated FAK, alone or in combination with SHP-2 and
SFK, participates in turn in adhesion-dependent Rho inhibi-
tion, modulating the focal adhesion turnover required for
cell spreading (Ren et al., 1999).
Our observation that FRNK inhibits 50% of integrin-
induced ERK activation, independently of the coexpressed
SHP-2 form, supports the 397Y-FAK phosphorylation de-
pendence of integrin-induced ERK activation (Schlaepfer
and Hunter, 1997). FRNK also inhibits ERK activation in
nonattached LCK-SHP2 cells. The simplest interpretation
of these results is that FAK is downstream of SHP-2; ac-
cordingly, SHP-2C/S expression inhibits ERK and delays
397Y-FAK phosphorylation. Thus, a possible pathway from
SHP-2 to ERK may be mediated via FAK.
Despite these correlations, FAK and SHP-2 may activate
ERK independently; indeed, maximum ERK activation pre-
cedes maximum 397Y-FAK phosphorylation. This uncou-
pling of FAK phosphorylation and ERK activation suggests
the existence of a FAK-independent pathway, which may
nonetheless be regulated by SHP-2. We do not observe
SHP-2 phosphorylation in unstimulated or Fn-attached cells
(unpublished data), indicating that the SHP-2/Grb2/SOS
pathway (Bennett et al., 1994) is not relevant for SHP-2–
induced ERK activation downstream of integrins. An in-
triguing possibility is that SHP-2 cooperates with a major in-
tegrin-stimulated pathway to further enhance ERK activation.
SHP-2 and its Drosophila homologue, Corkscrew, regulate
RasGAP targeting and activation downstream of the platelet-
derived growth factor receptor and Torso, respectively, abro-
gating Ras inactivation (Klinghoffer and Kazlauskas, 1995;
Cleghon et al., 1996). It is attractive to speculate that SHP-2
may regulate both Rho and p120RasGAP activity by control-
ling p190RhoGAP phosphorylation, a GAP for Rho and a
binding partner for RasGAP (Kulkarni et al., 2000).
SHP-2 is a specific regulator of Rho
The link between SHP-2 and Rho is particularly interesting,
as both are implicated in cell migration. Previous results
placed SHP-2 upstream of Rho, although there is contro-
versy as to whether SHP-2 regulates Rho activity positively
(Inagaki et al., 2000b; O’Reilly et al., 2000) or negatively
(Kodama et al., 2000; Schoenwaelder et al., 2000). SHP-2–
induced Rho inhibition is consistent with the larger numbers
of focal contacts and actin stress fibers in cells express-
ing loss-of-function SHP-2 or SHP-2C/S. Thus, the LCK-
SHP2C/S cell phenotype resembles that of FAK	/	 and SYF
(Src	/	Yes	/	Fyn	/	) cells, which fail to inhibit Rho after
adhesion (Arthur et al., 2000; Ren et al., 2000); thus, aber-
rant adhesion to substrate may cause the migration defects
seen in these cells (Yu et al., 1998; Mañes et al., 1999b).
Nonetheless, the model of SHP-2 as a constitutive negative
regulator of Rho is inconsistent with the defects in polarized
extension and spreading of SHP-2–deficient cells.
Our results suggest that SHP-2 functions as a positive or
negative regulator of Rho activity, depending on cellular
context. Fibronectin replating results indicate that func-
tional SHP-2 is required for 293T adhesion (Fig. 1 B), and
that the active LCK-SHP2 form is in fact a positive Rho
Figure 10. Model of SHP-2 function downstream of integrins. 
Schematic representation of the SHP-2 signaling pathways down-
stream of integrins. See Discussion for details.
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modulator. This experiment may mimic integrin-initiated
signaling events at the leading edge of migrating cells. None-
theless, SHP-2 is also essential for Rho inactivation after ad-
hesion occurs. SHP-2–induced Rho inactivation may occur
directly by activating Rho-GAP or inactivating Rho-GEF, or
indirectly by regulating FAK phosphorylation. Indeed, FAK
activity is necessary for Rho inactivation after adhesion (Ren
et al., 2000); concurring with other results (Oh et al., 1999),
we found that SHP-2 activity is required for FAK activation.
As Rho activity is also involved in FAK activation, SHP-2
may be part of the negative feedback mechanism that con-
trols focal adhesion turnover by regulating Rho and/or FAK
signaling pathways. This mechanism operates in rafts, pro-
viding spatial organization for these signaling networks. The
importance of positive and negative Rho regulation is under-
scored, as both constitutive activation and inhibition of Rho
suppress migration. Thus, dual regulation of Rho by SHP-2
may explain the physiological role of this phosphatase in reg-
ulating focal adhesion turnover and, hence, in modulating
the spreading and motile status of cells.
Materials and methods
Materials
Surfact-Amps X-100 containing 10% Triton X-100 was from Pierce Chemi-
cal Co; Optiprep gradient medium was from Nycomed Pharma; fibronec-
tin, methyl--cyclodextrin, p-nitrophenyl phosphate (pNPP), water-soluble
Cho, poly-L-lysine, BSA, and biotin- and FITC-labeled CTx B subunit were
from Sigma-Aldrich; Src inhibitor PP2, PP3, and latrunculin-B were from
Calbiochem; and ECL and [-32P]ATP were from Amersham Pharmacia
Biotech.
Antibodies used included the following: anti–SHP-2, -caveolin-1, -FAK,
and anti-pan Src (Santa Cruz Biotechnology); anti-1 integrin (Chemicon
International); anti-TfR and -ERK1/2 (Zymed Labs); anti–phospho-ERK1/2
(Cell Signaling Technology); anti–phospho-FAK (397Y and 861Y) and –phos-
pho-Src (527Y) (Biosource); anti-6His (CLONTECH Laboratories, Inc.); anti-
FAK and -paxillin (Transduction Labs); and anti-phosphotyrosine (PY)
4G10, -Rho, -Rac, and the Rho and Rac activation kits were from Upstate
Biotechnology. Peroxidase- and Cy3-labeled secondary antibodies were
from Dako and Jackson ImmunoResearch, respectively. Anti-HA antibody
was from Babco.
Cloning and expression constructs
cDNA coding for cytShp-2 (wt), cytShp-2C/S, the 
Shp-2, and 
Shp-2C/S
mutants lacking the two SH2 domains, and the Src-Shp2 and Src-Shp2C/S
chimeras containing 14 amino acids from the c-Src N terminus (MGSNK-
SKPKDASQR) (Zhao and Zhao, 1999) were a gift of Dr. Z.J. Zhao (Vander-
bilt University, Nashville, TN). The Lck-Shp2 chimera was obtained by
subcloning the first 12 amino acids from Lck (MGCGCSSHPEDD) at the wt
Shp2 N-terminal. Before transfection, all constructs were subcloned in
pcDNA3.1/Myc-His (Invitrogen) using standard procedures. HA-tagged
FRNK and GFP-tagged N19Rho, and N17Rac were gifts of Drs. D.
Schlaepfer (Scripps Research Institute, La Jolla, CA) and F. Sánchez-Madrid
(Hospital de la Princesa, Madrid, Spain), respectively.
Cell culture
HEK-293T human embryonic kidney cells (American Type Culture Collec-
tion) were maintained in DME with 10% FCS, L-glutamine, sodium pyru-
vate, and antibiotics. Cells were transiently transfected with the plasmids
using the standard calcium phosphate method. Transfection efficiency, de-
termined after 48 h, was 60–70% for SHP-2 constructs, 55% for N17Rac-
GFP, and 30% for N19Rho-GFP. 293T cells stably expressing FRNK were
selected in hygromycin (75 g/ml), and expression examined by Western
blot using anti-HA antibody.
Adhesion and spreading assays
For adhesion experiments, 96-well plates were coated (16 h, 4C) with Fn
(10-0.01 g/ml) or poly-L-lysine (0.5 mg/ml). 293T or 293T-FRNK cells ex-
pressing SHP-2 chimeras were serum starved in DME/0.1% BSA (4 h,
37C); after trypsinization, 3  104 cells/well were plated (15 min, 37C).
After washing, adhered cells were estimated by MTS (Promega) conver-
sion. Each condition was assayed in quadruplicate.
For spreading analysis, serum-starved 293T- or 293T-FRNK cells ex-
pressing the indicated SHP-2 constructs (106/ml) were trypsinized, resus-
pended in DMEM/BSA and plated on Fn-coated (10 g/ml) dishes for indi-
cated times. Spread cells were determined by dark-phase counting (200)
from eight fields. To analyze the effect of Cho depletion, 293T cells were
treated with 10 mM CD (30 min, 37C); after washing, some CD-treated
cells were incubated (30 min, 37C) in medium containing 30 g/ml free
Cho. Cho was removed by washing with DMEM/BSA and untreated-, CD-
treated and Cho-replenished (CDCho) cells were then replated on Fn as
above.
Western blotting and immunoprecipitation
In general, serum-starved 293T or 293T-FRNK cells expressing the SHP-2
forms were trypsinized; part were maintained in suspension (10 min,
37C), washed twice in phenol red-free DME/BSA, and the pellet was lysed
as below. The remaining cells were plated on Fn (10 g/ml) for the times
indicated. After washing to remove nonadhered cells, cells were lysed in
modified RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% SDS,
0.5% sodium deoxycholate, 1% Triton X-100) with a protease and phos-
phatase inhibitor cocktail. In some experiments, suspended cells were
treated with PP2, PP3, or latrunculin-B (in all cases 10 M, 30 min, 37C)
with continuous shaking before replating on Fn.
Protein concentration was determined using the Micro BCA protein as-
say (Pierce Chemical Co.). For immunoprecipitation, lysates (200 g) were
diluted with 200 l of lysis buffer containing the appropriate antibody at
the concentration indicated by the manufacturer; after incubation (2 h,
4C), antibodies were precipitated with anti–mouse IgG or protein
G-Sepharose beads. Total cell lysates (20 g/lane) or immunoprecipitated
proteins were separated by SDS-PAGE and probed with the indicated anti-
bodies, followed by PO-labeled second antibody and ECL.
SRC in vitro kinase assay
Cell lysates were precipitated with anti-pan SRC antibody (2 h, 4C) and
the pellet washed with ice-cold 50 mM Tris-HCl, pH 7.5, 100 mM NaCl,
10 mM MnCl2. Pellets were resuspended in 50 l of kinase buffer (50 mM
Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM Na2VO4, 1 M ATP, and 10 Ci
[-32P]ATP) and incubated (10 min, 20C) before adding 4 sample buffer
to terminate the reaction. Radioactivity was quantified after SDS-PAGE
with Storm 840 Phosphorimager/Image-QuaNT software (Molecular Dy-
namics).
SHP-2 in vitro phosphatase assay
Cell lysates from serum-starved 293T cells expressing the distinct SHP-2
mutants were immunoprecipitated with anti–SHP-2-agarose or anti-6His
antibodies (2 h, 4C). The beads capturing total (anti–SHP-2) or expressed
SHP-2 chimeras (anti-6His) were suspended in 50 l of assay buffer (20
mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM DTT and 1 mM EDTA), and
the reaction was initiated by adding 50 l of assay buffer containing 24
mM pNPP. After incubation (1 h, 37C), the reaction was terminated with
10 l of 5 N NaOH, and the amount of p-nitrophenol released was deter-
mined by absorbance at 405 nm; under these conditions, the reaction pro-
ceeded in a dose- and time-dependent manner.
Triton X-100 flotation experiments
For flotation gradients, serum-starved 293T cells were plated on Fn (10 g/
ml), and after the indicated times, plates were washed with ice-cold PBS
and scraped into 300 l TXNE buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 5 mM EDTA, 0.2% Triton X-100) containing a protease and phos-
phatase inhibitor cocktail. Extracted cells were brought to 35% Optiprep
and overlaid with 3.5 ml 30% Optiprep in TXNE and 200 l TXNE in an
SW60 tube. After centrifugation (4 h, 170,000 g, 4C), five fractions were
collected from top to bottom of the gradient, and normalized protein
amounts for each fraction were analyzed in Western blot.
Immunofluorescence
Serum-starved cells were trypsinized and then maintained in suspension or
plated on Fn-coated 8-well chamber glass slides (Nunc). After fixing (1%
paraformaldehyde, 5 min, 4C), cells were incubated with FITC-CTx (6 g/
ml, 10 min, 12C) and blocked with 5% goat serum/0.2% BSA before addi-
tion of anti–397Y-FAK, -paxillin, -SHP-2, or -1 antibody diluted in PBS/
BSA/1% goat serum. When antibodies to intracellular proteins were used,
cells were permeabilized with 0.1% Triton X-100 (10 min, 4C). Finally,
samples were incubated with the appropriate Cy3- or Cy2-conjugated sec-
ond antibody (1 h, 4C), and slides were mounted in Vectashield medium
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containing DAPI (Vector Labs) for confocal microscopy analysis (Leica).
When two colors were used, signal intensities for both fluorophors were
covered by a linear pixel scale. Digital images were processed using Pho-
toshop (Adobe Systems).
Rho and Rac activation assay
Starved cells (2  107) were maintained in suspension or plated on Fn for
the times indicated. Cell lysates were prepared using the reagents in the
Rho or Rac activation assay kit; GTP-bound Rho was precipitated with
RBD-agarose beads and GTP-Rac with PBD-agarose beads, according to
manufacturer’s instructions. The amount of Rho and Rac in the pellets was
determined by Western blot with specific antibodies, using crude cell ex-
tracts for normalization. Densitometry was performed using NIH Image
software.
Online supplemental material
Online supplemental Figs. S1–4 (available at http://www.jcb.org/cgi/
content/full/jcb.200109031/DC1) are the single color images from Figs. 2,
B–G, 4 A, 5 A, and 6 E, respectively.
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